한국식생활문화학회지 (Journal of the Korean Society of Food Culture)

  • 제25권6호
  • /
  • Pages.839-846
  • /
  • 2010
  • /
  • 1225-7060(pISSN)
  • /
  • 2288-7148(eISSN)
한국식생활문화학회 (Korean Society of Food Culture)
권호 표지
DOI QR코드

DOI QR Code

두충차 추출액이 알루미늄 투여 흰쥐의 알루미늄 축적률과 각종 장기 기능에 미치는 영향

Effects of Eucommia ulmodies Oliver Tea Extract on aluminum Accumulation Rate and Tissue Function in Aluminum-administered Rats

  • 한성희 (원광보건대학 식품영양학과)
  • Han, Sung-Hee (Department of Food & Nutrition, Wonkwang Health Science Unuversity)
  • 투고 : 2010.07.26
  • 심사 : 2010.11.04
  • 발행 : 2010.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

본 연구는 농도를 달리한 알루미늄 급여가 두충의 효과에 미치는 영향을 실시한 결과 식이섭취량에서 두충차 추출액과 알루미늄 병합급여군은 알루미늄 단독급여군에 비하여 증가하였으나 각 실험군간에 유의성은 나타나지 않았다. 음용수 섭취량은 알루미늄 단독 급여군에 비하여 알루미늄과 두충차 추출액 병합급여군이 약간 증가하였다. 체중 증가량은 대조군과 두충차 추출액 급여군에 비하여 농도를 달리한 알루미늄 급여군이 감소하였으며 식이효율은 각 실험군간에 유의적인 차이는 나타나지 않았다. 간, 심장, 신장, 폐, 위, 소장, 대장 및 비장 조직 중의 알루미늄 함량에서 대조군과 두충차추출액급여군 간에는 별다른 차이를 보이지 않았으나 각각의 농도를 달리한 알루미늄 급여군에 비하여 알루미늄과 두충차 추출액 병합급여군의 함량은 감소하였다. 레닌활성도에서 대조군에 비하여 두충차 추출액 급여군이 감소하였고, 각각 농도를 달리한 알루미늄 급여군에 비하여 알루미늄과 두충차 추출액 병합급여군이 유의적으로 감소하였다. 알도스테론농도는 각각 농도를 달리한 알루미늄 급여군에 비하여 알루미늄과 두충 추출액 병합급여군이 유의적으로 감소하였다. ALT와 AST는 농도를 달리한 알루미늄 단독 급여군에 비하여 알루미늄과 두충차 추출액 병합 급여군이 유의적으로 감소하였다. LDHase는 알루미늄 급여군에 비하여 알루미늄과 두충차 추출액 병합급여군이 감소하였으나 유의한 차이는 없었다. ChEase는 농도를 달리한 알루미늄 단독급여군에 비하여 두충차 추출액과 알루미늄 병합급여군 및 대조군과 두충차 추출액군이 유의하게 증가하였다. 따라서 알루미늄을 만성적으로 섭취하게 되면 독성효과를 나타낼 수 있으나 두충차추출액이 알루미늄에 의해 손상된 조직과 AST, ALT, LDHase. ChEase 활성도, 레닌, 알도스테론 호르몬 농도에 어느정도 영향을 미치는 것으로 나타나 두충의 폴리페놀 성분이 알루미늄에 의한 어느 정도 중독 완화 효과가 있으며, 본 실험은 흰쥐를 이용한 동물모델로 실시하였으나 알루미늄은 여러 경로를 통해 사람에게 노출 될 수 있으므로 알루미늄이 인체에 어떤 영향을 미치는지에 대한 연구는 계속되어져야 한다고 사료된다.

This study was designed to investigate the effects of Korean Eucommia ulmodies Oliver tea extract on aluminum administered rats. Forty-eight male Sprague-Dawley rats (100${\pm}$10 g) were divided into the following six groups; control group, 3% E. ulmodies tea extract group, 1,000 and 2,000 ppm aluminum ($Al_2(SO_4)_3$ in distilled water) groups, and 1,000 and 2,000 ppm aluminum plus 3% E. ulmodies tea extract groups. The aluminum content in the rat tissues of the aluminum administered group was lower than that in the rat tissue of the aluminum group administered 3% E. ulmodies tea extract. Asparate aminotransferase and alanine aminotransferase levels increased in the aluminum-administered group but were lower in the 3% E. ulmodies tea extract group. Lactate dehydrogenase was lower in the 3% extract E. ulmodies teaaluminum group than that in the aluminum group. Cholinesterase was higher in the 3% E. ulmodies tea-aluminum group than that in the aluminum group. Plasma renin activity levels increased in the aluminum administration group, compared with the aluminum plus 3% E. ulmodies tea group. Plasma aldosterone levels increased in the aluminum administration group compared with the aluminum plus 3% E. ulmodies tea group. These results suggest that an extract of E. ulmodies tea in water has lowering effects on the accumulation of aluminum. It is believed that the E. ulmodies tea had some protective effects in the aluminum-administered rats, but the mechanisms remain obscure.

키워드

참고문헌

  1. 喬木敬次郞, 木村正廉, 原田正敏, 大土家公男. 1982. 和漢藥物學, 東京, 南山堂. p 159
  2. Amador E, Dorfman E, Wacker WE. 1963. Serum lactic dehydrogenase activity an analytical assessment of current assays. Clin Chem, 8(12):391-399
  3. Armstrong RA, Winsper SJ, Blair JA. 1996. Aluminum and alzherimer's disease review of possible payhogenic mechanisms. Dementia, 7(1):1-9
  4. Aksari P, Stoppe G. 1996. Risk factors in alzheimer's dementia. Fortschritteder Neurologie-psychiartrie, 64(11):425-432 https://doi.org/10.1055/s-2007-996588
  5. Brenner BM, Rector FC. 1981. The kidney. Saunders, pp. 371-399, 650-679:723, 741
  6. Bergmeyer HU. 1995. Methods of enzymatic analysis. Verlag chemic, Academic press weinheim, 6(1):20-28
  7. Berlyne, NC, Yagil. R, Ben Ari J, Weinberger G, Knopf E, Danovith GM. 1972. Aluminum toxicity in rats. Lancet, 299(7750): 546-567
  8. Bioshop NJ, Morley R, Day JP, Lucas A. 1997. Aluminum neurotoxicity in preterm infants receving intravenous-feeding solution. N Engl J Med, 336(22):1557-1561 https://doi.org/10.1056/NEJM199705293362203
  9. Bowen DM, Benren JS, Allen SJ, Good hardt MJ. 1983. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzherimer's disease. J Neurochem, 41(1):266-272 https://doi.org/10.1111/j.1471-4159.1983.tb11838.x
  10. Candy JM, Oakley AE, Klinowski J, Carpenter TA, Perry RH, Attack JR, Perry EK, Blessed G, Fairbrain A, Edwawdson JA. 1986. Aluminosilicates and sensile plague formation in Alzherimer's disease. Lancet, 327(8477):354-356 https://doi.org/10.1016/S0140-6736(86)92319-6
  11. Cho KW, Malvin RL. 1979. Renin inactivation during in vitro. Experimental Am J Physiol, 236(4):501-504
  12. Cho KW, Kim SH. 1982. Factors affecting the relationship between renal renin activity and plasma renin activity. Kor J Physiol, 16(1):63-69
  13. Cho KW, Kim SH, Koch GY. 1987. Radioimmunoassay and characterization of renin-angiotensin system in the fresh water turtle. J Exp Zool, 242(3):255-262 https://doi.org/10.1002/jez.1402420303
  14. Cho KW, Kim SH, Koh GY, Seul KH, Huh KS, Chu D, Rap NS, Moon HB, Kim KK, Kook YJ. 1989. Plasma concentration of atrial natriuretic peptide in different phase of korean hemmorrhagic fever. Nephron, 51(2):215-219 https://doi.org/10.1159/000185288
  15. Choi BS, Park YJ, Kweon IH, Hong YP, Park JD. 2002. Reference values of mercury in liver and kidney of korean. Korean J Environ Toxicol, 17(2):119-115 https://doi.org/10.1002/tox.10040
  16. Chung Y, Hwanf MS, Yung GY, Jo SJ. 1999. Health risk assessment of lead exposure through multi-pathways in korea. Korean J Environ Toxicol, 14(4):203-216 https://doi.org/10.1002/(SICI)1522-7278(199902)14:1<203::AID-TOX26>3.0.CO;2-X
  17. Deloncle R, Huguet F, Babin P, Fermandez B, Quellard N, Guillard O. 1999. Chronic administration of aluminum L-glutamate in young mature rats, effects in iron levels and lipid peroxidation in selected brain areas. Toxicology letters, 10(1):65-73
  18. El-Maraghy SA, Gad MZ, Fahim AT, Hamdy MA. 2001. Effects of cadmiun and aluminum intake in the antioxidant state and lipid peroxidation in rat tissues. J Biochem Molecular toxicoligy, 15(2):207-214 https://doi.org/10.1002/jbt.18
  19. Ganje JJ, Page AL. 1976. Rapid acid dissoulation of plant tissue for cadium determination by atomic absorption spectrophotometry. At Absorpt Newsl, 131(37):108-110
  20. Ginsberg AL. 1970. Very high levels of SGOT and LDH in patients with extrahepatic billiary tract obstruction. J Amer Dig Dis, 15(9):803-805 https://doi.org/10.1007/BF02236040
  21. Goodfriend TL, L Levine, Fasma GD. 1964. Antibodies to bradykinin and angiotensin. A use of carbodiimide in immunololgy. Science, 144(2):1344-1346 https://doi.org/10.1126/science.144.3624.1344
  22. Han SH, Shin MK. 2005. Effects of water in extracts of pueraria radix on serum enzymes activities in aluminumadministerates. J Korean Soc Food Culture, 20(1):113-122
  23. Hsieh CI, Yen GC. 2000. Antioxidant actions of du-zhong (Eucommia ulmoides oliver) toward oxidative damage in biomoleucules. Life Sci, 66(5):1387-1400 https://doi.org/10.1016/S0024-3205(00)00450-1
  24. John MC,Quinlan GJ, Clark I, Halliwell B. 1985. Aluminum salts accerate peroxidation of menbrane lipids stimulated by iron salts. Biochem Biopaths Acta, 835(3):441-447 https://doi.org/10.1016/0005-2760(85)90113-4
  25. Jeffery EH, Abreo K, Burgess E, Cannata J, Greger LJ. 1996. Systemic aluminum toxicity; effects on bone, hematopoietic tissue, and kidney. J Toxicology environmental health, 48(6):649-665 https://doi.org/10.1080/009841096161122
  26. Karmen A. 1955. A note on the spectrophtometric assay of glutamic oxaloacetic transaminase in human blood serum. J Clinic Invest, 95(1):131-139
  27. Krischbaum BB, Werth AC. 1989. Acute aluminum toxocity associated with oral citrate and aluminum-containg antacids. American Journal of Medical sciences, 297(1):9-11 https://doi.org/10.1097/00000441-198901000-00003
  28. Landsberg JP, Mc Donald B, Watt F. 1992. Absence of aluminum in neuritic plague cores in Alzherimer's disease. N ature, 360(1):65-68 https://doi.org/10.1038/360065a0
  29. Lee IK, Kim JG. 2000. Effects of extract of eucommia ulmoides oliver on the reduction of lead and cadmium in organs rats. J Korean Public Health Assoc, 26(1):22-28
  30. Lee HS. 1992. Analysis of aluminum concentration in serum and phospholipid composition and catecholamin concentration in the brain of rats feed aluminum in drinking water. Dept of food. sukmong univ.
  31. Marquis & Black. 1984. Aluminum activation and inactivation of bovine caudate acetylcholinerserase. Bull Environ Contam Toxicol, 32(1):704-710 https://doi.org/10.1007/BF01607560
  32. Metori K, Furutsu M, Takahashi S. 1997. The preventive effect of ginseng with Du-zhong leaf on protein metabolism in aging. Biol Pharm Bull, 20(3):237-242 https://doi.org/10.1248/bpb.20.237
  33. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. 1995. Effects of lycopene on spontaneous mammary tumour development in SHN virgin mice. Anticancer Res, 15(4):1173-1178
  34. Nakamura T, Nakazawa Y, Onizuka S, Satoh S, Chiba A, Sekihashi K, Miura A, Yasugahara N, Sasaki Y. 1997. Antimutagenicity of Tochu tea; 1. The clastogen-suppressing effect of Tochu tea in CHO cells and mice. Mut Res, 38(1):7-20
  35. Neill D, Leake A, Hunghes D, Keith AB, Taylor GA, Allsop D, Rima BK, Morris C, Candy JM, Edwardson JA. 1996. Effect of aluminum on expression and processing of amyloid precursor protein. J of Neuroscience Reserach, 46(4):395-403 https://doi.org/10.1002/(SICI)1097-4547(19961115)46:4<395::AID-JNR1>3.0.CO;2-B
  36. Park SA, Choi MS, Jung UJ, Kim MJ, Kim DJ, Park HM, Park YB, Lee MK. 2006. Eucommia ulmoides oliver leaf extractincreases endogenous antioxidant activity in type 2 diabetic mice. J Med Food, 9(3):472-479
  37. Reitman S, Frankel S. 1957. A Colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer J Clin Pathol, 28(1):56-60 https://doi.org/10.1093/ajcp/28.1.56
  38. Rhee SJ, Hung PC. 1989. Metallothionein accumulation in CHO, cd cells in response to lead treatment. Chem Biol Interations, 72(3):347-361 https://doi.org/10.1016/0009-2797(89)90009-4
  39. Sasaki Y, Satoh, S, Chiba A, Murakami M, Sekihashi K, Tanaka M, Moribayashi N, Kudou C, Hara Y, Nakazawa Y, Nakamura T, Onizuka O. 1996. Antimutagenicity of Tochu tea 2. Suppressing effect of tochu tea. Mut Res, 371(3):203-214 https://doi.org/10.1016/S0165-1218(96)90108-1
  40. Salib E Hillier V. 1996. Acase-control study of alzherimer's disease and aluminum occupation. Brith J Psychiatry, 168(2):244-249 https://doi.org/10.1192/bjp.168.2.244
  41. Sedman AB, Wikening GN, Bradely PD, Warady BA, Lum GM, Alfrey AC. 1984. Encephalopathy in childhood secondary to aluminum toxicity. Journal of pediatrics, 105(5):835-836
  42. Sealey JE, Laragh JH. 1973. Searching out low renin patients limitation of some commonly used methods. Am J Med, 55(3):303-314 https://doi.org/10.1016/0002-9343(73)90132-0
  43. Wroblewski F, LaDue JS. 1955. Lactic dehydrogenase activity in blood. Proc Soc Exper Biol Med, 90(1):210-213 https://doi.org/10.3181/00379727-90-21985
  44. Yoshida H, Yoshimasu F. 1996. Alzherimer's disease and trace elements. Nippon rinsho Japanese. J Clin Med, 54(1):111- 116